• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Aust N Z J Psychiatry . Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19

tetano

Editor, Senior Moderator
Aust N Z J Psychiatry


. 2020 Oct 1;4867420961472.
doi: 10.1177/0004867420961472. Online ahead of print.
Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19


Christos Pantelis[SUP] 1 2 3 4 [/SUP], Mahesh Jayaram[SUP] 1 2 4 [/SUP], Anthony J Hannan[SUP] 3 [/SUP], Robb Wesselingh[SUP] 5 [/SUP], Jess Nithianantharajah[SUP] 3 [/SUP], Cassandra Mj Wannan[SUP] 1 [/SUP], Warda Taqdees Syeda[SUP] 1 [/SUP], Kh Christopher Choy[SUP] 3 6 [/SUP], Daniela Zantomio[SUP] 7 [/SUP], Arthur Christopoulos[SUP] 6 [/SUP], Dennis Velakoulis[SUP] 1 4 8 [/SUP], Terence J O'Brien[SUP] 5 9 [/SUP]



Affiliations

Abstract

Although COVID-19 is predominantly a respiratory disease, it is known to affect multiple organ systems. In this article, we highlight the impact of SARS-CoV-2 (the coronavirus causing COVID-19) on the central nervous system as there is an urgent need to understand the longitudinal impacts of COVID-19 on brain function, behaviour and cognition. Furthermore, we address the possibility of intergenerational impacts of COVID-19 on the brain, potentially via both maternal and paternal routes. Evidence from preclinical models of earlier coronaviruses has shown direct viral infiltration across the blood-brain barrier and indirect secondary effects due to other organ pathology and inflammation. In the most severely ill patients with pneumonia requiring intensive care, there appears to be additional severe inflammatory response and associated thrombophilia with widespread organ damage, including the brain. Maternal viral (and other) infections during pregnancy can affect the offspring, with greater incidence of neurodevelopmental disorders, such as autism, schizophrenia and epilepsy. Available reports suggest possible vertical transmission of SARS-CoV-2, although longitudinal cohort studies of such offspring are needed. The impact of paternal infection on the offspring and intergenerational effects should also be considered. Research targeted at mechanistic insights into all aspects of pathogenesis, including neurological, neuropsychiatric and haematological systems alongside pulmonary pathology, will be critical in informing future therapeutic approaches. With these future challenges in mind, we highlight the importance of national and international collaborative efforts to gather the required clinical and preclinical data to effectively address the possible long-term sequelae of this global pandemic, particularly with respect to the brain and mental health.

Keywords: SARS-CoV-2; anosmia; neuroinflammation; neuropsychiatric complications; vertical transmission.
 
Back
Top Bottom